Subcutaneous somatotropin vs placeboChange in quality of life · children and adults with SMA types II and III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted19 participantsVery low